Temperature Management (Therapeutic Hypothermia) Market is expected to grow at a CAGR of 6.5% during the forecasting period (2020-2027).

Published Date: 2021-04-28


DataM forecast the Temperature Management (Therapeutic Hypothermia) Market is anticipated to grow at a CAGR of 6.5% from 2020 to 2027

The global targeted temperature management (therapeutic hypothermia) market was valued at USD 2,548.9 million in 2019 and expected to grow at a CAGR of 6.5% to reach a market value of USD XX million by 2027.

Therapeutic hypothermia, also known as targeted temperature management or protective hypothermia, is reduction of body temperature, from 32 °C to 34 °C for faster recovery. Therapeutic hypothermia is crucial in the treatment of cardiovascular conditions like cardiac arrests and myocardial infarction. It improves neurological functioning after resuscitation from cardiac arrest. Temperature management involves heating or cooling to maintain a normal core body temperature. The basic procedure includes intentional hypothermia(condition of low body temperature), rewarming from hypothermia, or maintaining normal desired core body temperature. 

The implementation of a patient temperature management system leads to a reduction in surgical site infections, reduction in the length of hospital stays, which contributes to reducing treatment cost. TTM is used in various clinical areas such as neurology, cardiovascular conditions like cardiac arrests and myocardial infarction, and sepsis. It is considered as an established protective adjunct in neurosurgeries, cardiovascular surgeries and endovascular aneurysm repair

Market Dynamics


  • Increasing prevalence of cancer and cardiovascular diseases
  • The rising number of surgical procedures
  • Development of technologically advanced systems


  • High cost of temperature management systems
  • Adverse patient outcomes in typical medical conditions


  • Innovation of new induction processes
  • Rising private healthcare sector

Innovation of new induction processes

  • The evolution of Esophageal temperature management (ETM) is surging the adoption of targeted temperature management in neurological disorders. 
  • It has also noted to pose low adverse event risk, thus offering superior reliability over invasive TTM technologies
  • ensoETM, a Esophageal Cooling Device developed by Attune Medical received CE approval for use with most of the TTM devices in Europe market
  • Other novel technologies such as peritoneal and trans-nasal cooling systems are under investigation for their efficacy. The development of these techniques may widen the adoption of TTM globally.

Rising private healthcare sector

  • Despite the national coverage of the NHS, the trend of private care and health insurance is on rise.
  • The number of beds available in the private sector acute hospitals is growing faster than that in NKS hospitals
  • The growth of private healthcare institutions is likely to pose new growth opportunities for TTM devices

Geographical Analysis

The Asia-Pacific targeted temperature management market is valued at USD 563.9 Mn in 2019 and is estimated to grow at a CAGR of 6.3% over the forecast period to reach a USD YY Mn by 2027. Asia-Pacific region is also expected to show attractive growth over the forecast period due to the presence of high growth opportunities for the unmet needs of the target population, and growing medical tourism in Asian countries. Favorable government initiatives to modernize healthcare infrastructure coupled with the increasing number of hospitals is also expected to positively impact the temperature management market.  The substantial demand for targeted temperature management systems in the region can be attributed to rising surgical procedures and prevalence of chronic conditions, especially in geriatric populations.  For instance, according to the National Health Mission, there was a 10-fold rise in the number of surgeries in India between 2009-2010 and 2014-2015. Hence, growing number of surgeries, as well as road accidents in India, are also projected to drive regional market growth. 

The regional market will also make attractive strides in the coming years helped by vast improvements made in healthcare infrastructures and growing patient awareness in emerging economies such as India and China.

In addition, based on the World Heart Federation, the prevalence of cardiovascular diseases, such as stroke and ischemic heart disease, is projected to rise by 50% in China between 2010 and 2030. Hospitals are the largest usage area for patient warming systems in the country. Highest admissions and surgical interventions being performed in hospitals and widest use of patient warming systems in inpatient and operation settings are the key factors that support the dominance of hospitals. The increase adaption of targeted temperature management systems reduced the risk of inadvertent perioperative hypothermia during anesthesia and show significant impact on patients’ health outcome. However, high cost associated with temperature management systems is one of the major restricting factors for this market. The surgical procedure becomes expensive due to the use of temperature management systems such as endovascular methods. The cost per treatment for single-use components also increases.

For instance, Arctic 5000 and its related consumables are costly and require a team of specialists to handle the medical device. Thus, the price pressure and lack of availability of trained professionals hamper the growth of market in the region.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com


Related News


      Related Releases

        Get your FREE SAMPLE PROPOSAL with a single click!